2302 Multicenter phase II study of trastumab in combination with 5-weekly S-1 plus CDDP in HER2-positive advanced gastric cancer. (September 2015) - Mizushima, T.; Kataoka, H.; Mori, Y.; Sobue, S.; Kawai, T.; Senoo, K.; Nakamura, M.; Sano, H.; Joh, T.